Navigation Links
September is Leukemia, Lymphoma and Myeloma Awareness Month
Date:9/12/2007

Tremendous advances have been made to treat blood cancer but the battle is

far from won

WHITE PLAINS, N.Y., Sept. 12 /PRNewswire/ -- Remarkable progress has been made in treating patients with blood cancers. Sixty years ago there were few effective treatments for children or adults with blood cancer and the rate of survival was very low. Today, about 75 percent of children with acute leukemia and nearly 80 percent of children and adults with Hodgkin lymphoma are cured. Improved therapies and stem cell transplantation have dramatically improved survival rates for most blood cancers, and even patients with diseases resistant to treatment, such as myeloma, are benefiting from new drugs that are increasing the rate and duration of remissions.

Yet, more than three quarters of a million people in the United States currently have some form of blood cancer. Every ten minutes someone dies from a blood cancer and an estimated 52,310 will die from one this year.

The Leukemia & Lymphoma Society is a beacon of help and guidance to those touched by blood cancer and each September the Society observes Leukemia, Lymphoma and Myeloma Awareness Month, to shed light on these diseases and let the public know that there are resources available for blood cancer patients and their families.

"Awareness Month is an opportunity to increase the public's understanding of blood cancers and encourage people to support the funding of research to find cures and education programs to help patients have the best possible outcomes throughout their cancer experience," said Dwayne Howell, the Society's President and CEO.

Since its inception in 1949, the Society has invested more than $550 million in research to find cures and better therapies, and funded $64.9 million in 2007 alone. The Society supports investigators' efforts to find new molecular targets for treatment and potential immunotherapies, and helps them translate their labo
'/>"/>

SOURCE The Leukemia & Lymphoma Society
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. Dasatinib Shows High Early Response Rate as First Treatment for Chronic Myelogenous Leukemia, M. D. Anderson Researchers Report
2. Pixantrone Combination Therapy for First-line Treatment of Aggressive Non-Hodgkins Lymphoma Results in Reduction in Severe Toxicities Including Heart Damage When Compared to Doxorubicin-based Therapy
3. Based on Up to 6 Years of Follow-Up, Biovest Announces Favorable Interim Blinded Data for Fast-Tracked Pivotal Phase 3 Clinical Trial of BiovaxID Anti-Cancer Vaccine for Non-Hodgkins Lymphoma
4. Fractionated Radioimmunotherapy With (90)Y-epratuzumab in Non-Hodgkins Lymphoma Appears Safe and Active in a Phase I/II Study
5. Favrille Announces Data From Phase 2 Clinical Trial of FavId for Indolent B-Cell Non-Hodgkins Lymphoma in Europe
6. Gloucester Pharmaceuticals Reports Positive Interim Phase II Data on Romidepsin for T-Cell Lymphomas at the 2007 American Society of Clinical Oncology Annual Meeting
7. Nuvelo Announces Publication of Preclinical Study Results Demonstrating the Potential of NTB-A as a New Target for Leukemia and Lymphomas
8. Ontak (denileukin diftitox) Achieves 49.1% Overall Response Rate in Phase III Trial of Cutaneous T-Cell Lymphoma (CTCL)
9. Phase 2 Clinical Results of Ganite Plus Standard Therapy in Patients with Relapsed/Refractory Lymphoma Presented at ASCO
10. Phase 2 Clinical Results of Ganite Plus Standard Therapy in Patients with Relapsed/Refractory Lymphoma Presented at ASCO
11. MabThera Significantly Extends Survival And Cures More Patients With Aggressive Lymphoma Than Chemotherapy Alone
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/24/2014)... July 24, 2014  Restore Health, a leading ... pharmaceuticals, announced that it is now offering pharmacogenetics ... each individual based upon their particular genetic makeup. ... the interaction between a patient,s genetics and their ... excited to provide this new service to healthcare ...
(Date:7/24/2014)...  Uroplasty, Inc. (NASDAQ: UPI ), a ... innovative proprietary products to treat voiding dysfunctions, today ... quarter ended June 30, 2014.  Global revenue ... grew 19% to $4.1 million, as compared to ... prior year.  Total revenue for the fiscal first ...
(Date:7/24/2014)... Calif. , July 24, 2014  IRIDEX Corporation ... will release its second quarter 2014 financial results after ... In conjunction with the release, the Company will ... 5:00 p.m. Eastern Time on Thursday, ... the quarter and other business developments. Interested ...
Breaking Medicine Technology:Restore Health Launches Pharmacogenetic Testing, Enhancing Its Suite of Personalized Medicine Goods and Services 2Restore Health Launches Pharmacogenetic Testing, Enhancing Its Suite of Personalized Medicine Goods and Services 3Uroplasty Reports Fiscal First Quarter Results 2Uroplasty Reports Fiscal First Quarter Results 3Uroplasty Reports Fiscal First Quarter Results 4Uroplasty Reports Fiscal First Quarter Results 5Uroplasty Reports Fiscal First Quarter Results 6Uroplasty Reports Fiscal First Quarter Results 7Uroplasty Reports Fiscal First Quarter Results 8Uroplasty Reports Fiscal First Quarter Results 9Uroplasty Reports Fiscal First Quarter Results 10Uroplasty Reports Fiscal First Quarter Results 11
... market dynamics offers insights into,what will be needed ... to,patients, NEW YORK, May 14, 2007 /PRNewswire-USNewsire/ -- ... a not-for-profit,product development partnership accelerating the discovery and,development ... the first,comprehensive study of the dynamics of the ...
... YORK--(BUSINESS WIRE)--May 15, 2007 - SIGA Technologies, Inc.,(NASDAQ: ... proof of,concept guinea pig trial of its lead ... under Biosafety Level 4 conditions at,the U.S. Army ... Kathleen Cashman under the supervision of Dr.,Mary Guttieri, ...
Cached Medicine Technology:New Study Reveals Limitations of a Complex and Challenging Global,Tuberculosis Drug Marketplace 2New Study Reveals Limitations of a Complex and Challenging Global,Tuberculosis Drug Marketplace 3New Study Reveals Limitations of a Complex and Challenging Global,Tuberculosis Drug Marketplace 4SIGA Passes First Hurdle with Lassa Fever Antiviral ST-193 2SIGA Passes First Hurdle with Lassa Fever Antiviral ST-193 3SIGA Passes First Hurdle with Lassa Fever Antiviral ST-193 4
(Date:7/24/2014)... Mellon University, working with high-throughput data generated by ... have devised a computational method to determine how ... turn malignant and as they respond to potential ... genes interact with each other in laboratory-grown cells ... the online journal PLOS Computational Biology . ...
(Date:7/24/2014)... Denver, CO (PRWEB) July 24, 2014 In ... the United States has officially put an end to criminal ... legislation marks a new era for marijuana reform in Washington ... in America. The new law replaces criminal penalties for possession ... fine. Growing, selling and the possession of more than an ...
(Date:7/24/2014)... from Penn Medicine shows that incisionless transcatheter aortic ... stay by 30 percent and has no impact ... conventional transfemoral TAVR, which requires an incision in ... the current issue of Circulation: Cardiovascular Interventions ... aortic valve without a traditional open-heart surgical approach. ...
(Date:7/24/2014)... Lynn E. Taylor, M.D., director of The ... the July, 2014 Rhode Island Medical Journal ... eliminating hepatitis c virus infection (hep c or ... capacity to address other health challenges, and improve ... the United States, Taylor says, include lack of ...
(Date:7/24/2014)... 2014 On October 24-25th, 2014, hundreds of ... the Embassy Suites LAX North for DiabetesSisters’ power-packed weekend conference. ... the first time it has convened Los Angeles, CA area. ... to open the entire event to both women with diabetes ... its kind worldwide for women with diabetes, the event offers ...
Breaking Medicine News(10 mins):Health News:Gene changes in breast cancer cells pinpointed with new computational method 2Health News:Gene changes in breast cancer cells pinpointed with new computational method 3Health News:Washington D.C. Decriminalizes Marijuana 2Health News:Penn study: Incisionless transcatheter aortic valve replacement surgery cuts hospital length of stay 2Health News:Miriam Hospital physician advocates awareness, collaboration to combat peaking hep C virus 2Health News:Miriam Hospital physician advocates awareness, collaboration to combat peaking hep C virus 3Health News:Miriam Hospital physician advocates awareness, collaboration to combat peaking hep C virus 4Health News:DiabetesSisters Brings Conference for Women with Diabetes Los Angeles for the First Time 2Health News:DiabetesSisters Brings Conference for Women with Diabetes Los Angeles for the First Time 3
... If you want to lose the kilos you,ve put on over ... to appetite play an important role in your likelihood of regaining ... highest levels of leptin and lowest levels of ghrelin are more ... Doctors often have to deal with patients who, after sticking to ...
... that a bacterium inside the worm acts as a ,disguise, ... it in an ineffective way. The bacteria protect the ... are removed with antibiotics, the immune system responds appropriately, releasing ... Antibiotics are successful against the parasite, but the long treatment ...
... HealthDay Reporter , TUESDAY, Jan. 11 (HealthDay News) -- ... and Advil, can raise the risk of heart ... suggests. Swiss researchers analyzed the results of 31 ... medications are called, and concluded that cardiovascular risk needs ...
... HealthDay Reporter , TUESDAY, Jan. 11 (HealthDay ... cancer surgery experience urinary incontinence afterward, but new research ... problems for a significant number of them. After ... pelvic exercises and bladder control techniques -- the researchers ...
... , TUESDAY, Jan. 11 (HealthDay News) -- The steady, ... and there has been an alarming increase in the number ... The abortion rate in 2008 was 19.6 per 1,000 women ... peak of 29.3 per 1,000 women, according to the nonprofit ...
... Launched on December 2, 2010, Healthy People 2020 ... health of all Americans. A key component, Education for ... People 2020 goals. Formulated by the Healthy People Curriculum ... objectives provides a vehicle for promoting the discussion and ...
Cached Medicine News:Health News:'Yo-yo' effect of slimming diets explained 2Health News:Study sheds new light on river blindness parasite 2Health News:Certain Painkillers Appear to Boost Odds for Heart Attack 2Health News:Certain Painkillers Appear to Boost Odds for Heart Attack 3Health News:Therapy May Help Cut Incontinence After Prostate Surgery 2Health News:Therapy May Help Cut Incontinence After Prostate Surgery 3Health News:Decline in U.S. Abortion Rate Stalls, Report Finds 2Health News:10-year roadmap for reaching public health education goals 2Health News:10-year roadmap for reaching public health education goals 3Health News:10-year roadmap for reaching public health education goals 4
... 30in(w) x 24in(d) x 24in(h). Designed ... amplification reactions. The PCR Workstation irradiates ... against cross or airborne contamination by limiting ... enviornment. Includes two fluorescent lights, one ...
... for highthroughput reading of tube racks. Its camera-based ... than one second per rack, making it ideal ... of the reader allows a rack to be ... robotic arms. An optical safety switch prevents a ...
Reads single TrakMates tubes instantly, and drops decoded tube number instantly into any Windows application. System includes reader and Windows based software....
... Polypropylene workbench top with ... adjustable from 25"-34". Available in ... Accessories include shelves, drawers, light ... is an expert in custom ...
Medicine Products: